Subscribe to RSS
DOI: 10.1055/s-0038-1654816
The Interaction of Contact Product and Factor IX[*]
Publication History
Publication Date:
22 June 2018 (online)

Summary
1. The activation of factor IX in recalcified plasma develops slowly and is accelerated by dilution of the resulting serum.
2. The complex process of activation and decay of the active product, introduces error into the assay method.
3. An excess or the complete removal of calcium ions eliminates the activation but does not prevent decay of the active product.
4. The assay of factor IX in plasma gives results similar to those for serum obtained from celite exhausted plasma.
5. Activation of factor IX is minimal in the serum obtained when plasma samples deficient in contact product, or the contact factors are clotted.
6. Plasma factor IX is probably activated enzymatically by calcium ions and contact product. The presence in serum of an inhibitor of the process was not clearly demonstrated.
* This work was carried out during the tenure of a fellowship awarded by The International Union Against Cancer and the Eleanor Roosevelt Cancer Foundation.
** Present address: Institut Gustave Roussy, 16bis. Avenue Paul Vaillant Courturier, Ville-juif, Seine, France.
-
References
- 1 Bachmann F, Duckert F, Fisch U, Streuli F, Gerber D, Koller F. Der Gerinnungsdefekt beim kongenitalen PTA-Mangel. Schweiz, med. Wschr. 88: 1037 1958;
- 2 Biggs R, Macfarlane R. G. Human Blood Coagulation and its Disorders. 3rd Ed.. Blackwells Scientific Publications; Oxford, England: 1962
- 3 Biggs R, Sharp A. A, Margolis J, Hardisty R. M, Stewart J, Davidson W. M. Defects in the Early Stages of Blood Coagulation. A Report of 4 Cases. Brit. J. Haemat. 04: 177 1958;
- 4 Biggs Rosemary, Bidwell Ethel, Handley D. A, Macfarlane R. G, Trueta J, Elliot-Smith A, Dike GWR, Ash B. J. The Preparation and Assay of a Christmas Factor (Factor IX) Concentrate and its Use in the Treatment of two Patients. Brit. J. Haemat. 07: 349 1961;
- 5 Clarke J. E. The Assay of Christmas Factor (Factor IX) in Normal and Pathological Sera. J. Med. Lab. Technol. 17: 163 1960;
- 6 Duckert F. Plasma Thromboplastin Antecedent and the Activation of Factor IX. Thrombos. Diathes. haemorrh. (Stuttg) 04: 145 1960; (supplement
- 7 Egli H. The influence of Glass Contact on the Assay of Factor IX. VIII th. Internat. Congress of Haematology; Tokyo: 1960
- 8 Lewis FJW, Eldin FNour. Factor IX in Intravascular and Extravascular Blood Coagulation. Blood 20: 41 1962;
- 9 Mustard J. F. The Serum Defect in Christmas Disease. Acta Haemat. 21: 321 1959;
- 10 Nossel H. L. The Contact Phase of Blood Coagulation. Blackwells. Scientific Publications Oxford; England: 1963
- 11 Ratnoff O. D, Davie E. W. The Activation of Christmas Factor by Activated Plasma Thromboplastin Antecedent. Biochemistry 01: 677 1962;
- 12 Soulier J. P. Surface Problems and Hageman Factor. Thrombos. Diathes. haemorrh. (Stuttg) 04 (Suppl.) 137 1960;
- 13 Soulier J. P, Prou- Wartelle O. New Data on Hageman Factor and Plasma Thromboplastin Antecedent. The Role of “Contact” in the Initial Phase of Blood Coagulation. Brit. J. Haemat. 06: 88 1960;
- 14 Soulier J. P, Wartelle O, Menache D. Caractères différentiels des facteurs Hageman et P.T.A. role du contact dans la phase initiale de la coagulation. Rev. franc. Etud. clin, biol. 03: 263 1958;